Retrospective Cohort Study
Copyright ©The Author(s) 2025.
World J Nephrol. Jun 25, 2025; 14(2): 101961
Published online Jun 25, 2025. doi: 10.5527/wjn.v14.i2.101961
Table 3 Median graft survival and median patient survival between the different body mass index categories

Underweight (< 5th)
Healthy weight (5th-85th)
Overweight (85th-95th)
Class 1 obese (95th-120%95th)
Class 2 obese (120%-140%95th)
Class 3 obese (> 140%95th)
Median graft survival (95%CI) (years)11.6 (10.9-12.3)b,c,d,e,f12.2 (11.9–12.4)a,e11.9 (11.4–12.4)a,e12.0 (11.4–12.6)a,e9.7 (8.7–10.6)a,e
11.8 (10.5–13.0)a,b,c,d,e
1-year graft survival rate92.2%f93.1%f92.6%f92.0%f92.7%f88.7%a,b,c,d,e
5-year graft survival rate71.3%b,c,d73.8%a,e,f73.1%a,e,f73.6%a,e,f67.8%b,c,d68.3%b,c,d
10-year graft survival rate45.0%b,c,d,f46.8%a,e47.0%a,e49.5%a,e40.7%b,c,d,f48.7%a,e
Median patient survival (95%CI) (years)26.9 (24.4-29.4)f26.0 (24.7-27.2)f24.8 (23.6–25.9)f24.8 (22.9-26.7)f23.1 (21.1-25.0)a,b,c,d
1-year graft survival rate 92.2%93.1%92.6%92.0%92.7%88.7%
5-year patient survival rate93.6%c,d92.5%c,d95.6%a,b,e,f94.6%a,b,e,f92.6%c,d91.3%c,d
10-year patient survival rate81.3%b,c,d85.5%a,e,f86.7%a,e,f86.1%a,e,f78.9%b,c,d79.9%b,c,d